What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Pathology, Genetics, Chromosome, Karyotype and Sarcoma are his primary areas of study.
His Pathology research is multidisciplinary, incorporating elements of Fluorescence in situ hybridization, Gene rearrangement and Cytogenetics.
The Chromosome study combines topics in areas such as Tumor type, Anatomy and Medical genetics.
Fredrik Mertens interconnects Trisomy, Comparative genomic hybridization and Synovial sarcoma in the investigation of issues within Karyotype.
His Sarcoma research is multidisciplinary, relying on both Immunohistochemistry, Solitary fibrous tumor and Leiomyosarcoma.
His Fusion gene study combines topics from a wide range of disciplines, such as Molecular biology, Cancer research and Chromosomal translocation.
His most cited work include:
- World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone (2103 citations)
- Pathology and genetics of tumours of soft tissue and bone (1284 citations)
- The impact of translocations and gene fusions on cancer causation (996 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Pathology, Genetics, Karyotype, Chromosome and Cytogenetics.
His work deals with themes such as Trisomy and Anatomy, which intersect with Pathology.
He frequently studies issues relating to Molecular biology and Genetics.
His research in Karyotype intersects with topics in Chromosome aberration, Carcinoma, Immunology and Medical genetics.
Fredrik Mertens has researched Chromosome in several fields, including Cancer, Somatic evolution in cancer and Gene rearrangement.
His Cytogenetics research includes elements of Carcinogenesis, Internal medicine and Aneuploidy.
He most often published in these fields:
- Pathology (45.82%)
- Genetics (33.65%)
- Karyotype (32.94%)
What were the highlights of his more recent work (between 2011-2021)?
- Pathology (45.82%)
- Gene (19.09%)
- Fusion gene (15.27%)
In recent papers he was focusing on the following fields of study:
Fredrik Mertens focuses on Pathology, Gene, Fusion gene, Genetics and Sarcoma.
His work carried out in the field of Pathology brings together such families of science as CD34 and Fluorescence in situ hybridization.
His biological study spans a wide range of topics, including MRNA Sequencing, Cancer research, ROS1 and Exon.
Chromosome, Breakpoint, Karyotype, Gene duplication and Deep sequencing are the primary areas of interest in his Genetics study.
His Karyotype study integrates concerns from other disciplines, such as Chromosome Band and Cytogenetics.
His Sarcoma research is multidisciplinary, incorporating perspectives in Gene rearrangement, Malignant peripheral nerve sheath tumor, Solitary fibrous tumor and Gene expression profiling.
Between 2011 and 2021, his most popular works were:
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal (860 citations)
- WHO Classification of Tumours of Soft Tissue and Bone: WHO Classification of Tumours, vol. 5 (390 citations)
- TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL (354 citations)
In his most recent research, the most cited papers focused on:
Fredrik Mertens spends much of his time researching Fusion gene, Pathology, Gene, Genetics and Fluorescence in situ hybridization.
His Fusion gene study incorporates themes from Computational biology, Karyotype and Exon.
His study ties his expertise on CD34 together with the subject of Pathology.
His work on DNA sequencing, Carcinogenesis, Chromosome and Cancer as part of general Genetics research is frequently linked to Fusion protein, bridging the gap between disciplines.
His Fluorescence in situ hybridization research integrates issues from MRNA Sequencing, NAB2, Fusion transcript, Breakpoint and Molecular biology.
In his study, which falls under the umbrella issue of Sarcoma, Exome sequencing and Telomere-binding protein is strongly linked to Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
